Monopar Therapeutics Statistics
Total Valuation
MNPR has a market cap or net worth of $253.49 million. The enterprise value is $193.28 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, before market open.
Earnings Date | May 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
MNPR has 6.11 million shares outstanding. The number of shares has increased by 37.09% in one year.
Current Share Class | 6.11M |
Shares Outstanding | 6.11M |
Shares Change (YoY) | +37.09% |
Shares Change (QoQ) | +39.27% |
Owned by Insiders (%) | 4.73% |
Owned by Institutions (%) | 24.02% |
Float | 3.50M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 4.60 |
P/TBV Ratio | 4.61 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.47
Current Ratio | 11.47 |
Quick Ratio | 11.46 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -51.42% and return on invested capital (ROIC) is -33.32%.
Return on Equity (ROE) | -51.42% |
Return on Assets (ROA) | -29.87% |
Return on Invested Capital (ROIC) | -33.32% |
Return on Capital Employed (ROCE) | -29.37% |
Revenue Per Employee | n/a |
Profits Per Employee | -$974,151 |
Employee Count | 16 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1,212.34% in the last 52 weeks. The beta is 1.02, so MNPR's price volatility has been similar to the market average.
Beta (5Y) | 1.02 |
52-Week Price Change | +1,212.34% |
50-Day Moving Average | 36.43 |
200-Day Moving Average | 20.05 |
Relative Strength Index (RSI) | 58.49 |
Average Volume (20 Days) | 24,239 |
Short Selling Information
The latest short interest is 51,820, so 0.85% of the outstanding shares have been sold short.
Short Interest | 51,820 |
Short Previous Month | 50,687 |
Short % of Shares Out | 0.85% |
Short % of Float | 1.48% |
Short Ratio (days to cover) | 1.62 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -16.16M |
Pretax Income | -7.12M |
Net Income | -15.59M |
EBITDA | n/a |
EBIT | -16.16M |
Earnings Per Share (EPS) | -$4.11 |
Full Income Statement Balance Sheet
The company has $60.21 million in cash and n/a in debt, giving a net cash position of $60.21 million or $9.85 per share.
Cash & Cash Equivalents | 60.21M |
Total Debt | n/a |
Net Cash | 60.21M |
Net Cash Per Share | $9.85 |
Equity (Book Value) | 55.04M |
Book Value Per Share | 9.02 |
Working Capital | 55.04M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -6.40M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
MNPR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -37.09% |
Shareholder Yield | -37.09% |
Earnings Yield | -6.15% |
FCF Yield | n/a |
Analyst Forecast
The average price target for MNPR is $59.50, which is 43.48% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $59.50 |
Price Target Difference | 43.48% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on August 13, 2024. It was a reverse split with a ratio of 0.2:1.
Last Split Date | Aug 13, 2024 |
Split Type | Reverse |
Split Ratio | 0.2:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |